
    
      Patient will continue to receive study medication until disease progression, unacceptable
      toxicity, withdrawal of informed consent, or other reason why investigator considers it
      appropriate to discontinue study medication. Once permanently discontinued, study medication
      cannot be restarted at later timepoint.
    
  